These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8922080)

  • 41. Screening and diagnosis of coagulation disorders.
    Lusher JM
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 2):778-83. PubMed ID: 8828561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease.
    Raffini LJ; Niebanck AE; Hrusovsky J; Stevens A; Blackwood-Chirchir A; Ohene-Frempong K; Kwiatkowski JL
    Pediatr Blood Cancer; 2006 Oct; 47(5):589-93. PubMed ID: 16123995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Using a Standardized Questionnaire for Coagulation Assessment in Children Undergoing Tonsillectomy].
    Wenzel A; Königstein M; Hörmann K; Umbreit C; Cazan D; Walliczek-Dworschak U; Stuck BA
    Laryngorhinootologie; 2017 May; 96(5):299-305. PubMed ID: 27832681
    [No Abstract]   [Full Text] [Related]  

  • 44. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Noonan syndrome with thrombocytopenia secondary to hypersplenism].
    Español I; Vendrell T; Mora J; Pujol-Moix N
    Sangre (Barc); 1999 Oct; 44(5):387. PubMed ID: 10618918
    [No Abstract]   [Full Text] [Related]  

  • 46. Risk of post-operative hemorrhage after adenoidectomy and tonsillectomy: Value of the preoperative determination of partial thromboplastin time and prothrombin time.
    Bitar M; Dunya G; Khalifee E; Muwakkit S; Barazi R
    Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():62-64. PubMed ID: 30554709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Review of patients studied for coagulopathy in a Hematology/Oncology unit].
    Romero I; Conde N; García Aldana D; Ruano A; Fernández-Teijeiro A
    An Pediatr (Barc); 2016 Feb; 84(2):85-91. PubMed ID: 26006274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Noonan Syndrome: An Underestimated Cause of Severe to Profound Sensorineural Hearing Impairment. Which Clues to Suspect the Diagnosis?
    Ziegler A; Loundon N; Jonard L; Cavé H; Baujat G; Gherbi S; Couloigner V; Marlin S
    Otol Neurotol; 2017 Sep; 38(8):1081-1084. PubMed ID: 28742629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment tailoring for factor V deficient patients and perioperative management using global hemostatic coagulation assays.
    Levy-Mendelovich S; Barg AA; Rosenberg N; Avishai E; Luboshitz J; Misgav M; Kenet G; Livnat T
    Blood Cells Mol Dis; 2018 Jul; 71():5-10. PubMed ID: 29402705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Investigation of coagulation time: PT and APTT].
    Ramakers C; van der Heul C; van Wijk EM
    Ned Tijdschr Geneeskd; 2012; 156(0):A3985. PubMed ID: 22917038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
    Tofil NM; Winkler MK; Watts RG; Noonan J
    Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative screening for coagulation disorders in children undergoing adenoidectomy (AT) and tonsillectomy (TE): does it prevent bleeding complications?
    Eisert S; Hovermann M; Bier H; Göbel U
    Klin Padiatr; 2006; 218(6):334-9. PubMed ID: 17080336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet and coagulation studies in Ehlers-Danlos syndrome.
    Anstey A; Mayne K; Winter M; Van de Pette J; Pope FM
    Br J Dermatol; 1991 Aug; 125(2):155-63. PubMed ID: 1911298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment.
    Noordam C; van der Burgt I; Sweep CG; Delemarre-van de Waal HA; Sengers RC; Otten BJ
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):53-9. PubMed ID: 11167926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short stature in Noonan syndrome: response to growth hormone therapy.
    Kirk JM; Betts PR; Butler GE; Donaldson MD; Dunger DB; Johnston DI; Kelnar CJ; Price DA; Wilton P; Group tU
    Arch Dis Child; 2001 May; 84(5):440-3. PubMed ID: 11316696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prevalence of bleeding disorders among healthy pediatric patients with abnormal preprocedural coagulation studies.
    Shaw PH; Reynolds S; Gunawardena S; Krishnamurti L; Ritchey AK
    J Pediatr Hematol Oncol; 2008 Feb; 30(2):135-41. PubMed ID: 18376266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis.
    Colley A; Donnai D; Evans DG
    Clin Genet; 1996 Feb; 49(2):59-64. PubMed ID: 8740913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coagulation changes during thoracoabdominal aneurysm repair.
    Gertler JP; Cambria RP; Brewster DC; Davison JK; Purcell P; Zannetti S; Johnson S; L'Italien G; Koustas G; LaMuraglia GM; Laposata M; Abbott WM
    J Vasc Surg; 1996 Dec; 24(6):936-43; discussion 943-5. PubMed ID: 8976347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
    Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
    Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
    Favaloro EJ; Zafer M; Nair SC; Hertzberg M; North K
    Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.